Viewing Study NCT03440892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-01-25 @ 4:54 AM
Study NCT ID: NCT03440892
Status: UNKNOWN
Last Update Posted: 2022-05-04
First Post: 2018-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
Sponsor: Vastra Gotaland Region
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None survivin View
None biomarker of pharmacological response View
None antirheumatic treatment View
None methotrexate View
None sulfasalazin View
None abatacept View
None tocilizumab View
None tofacitinib/baricitinib View